Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes

Clinical trial NCT00003138 · COMPLETED

Trial details

NCT number: NCT00003138
Sponsor: Eastern Cooperative Oncology Group
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia Myelodysplastic Syndromes

Start date: 1998-03-04
Primary completion: 2008-08-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.